ENWEI PHARMACEUTICAL
30133120.103.88% ( +0.75 )
ENWEI PHARMACEUTICAL (301331)
Enwei Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of Chinese medicines and chemical dru...
- Open
- 19.34
- High
- 20.11
- Low
- 19.28
- Prev. Close
- 19.35
- Volume
- 24.48K
- Turnover
- 48.61M
- Avg Price
- 19.85
- Bid/Ask Ratio
- -31.54%
- Amplitude
- 4.29%
- 52wk High
- 38.64
- Volume Ratio
- 1.00
- Turnover Ratio
- 2.38%
News
- Zhitong · Aug 28, 2025 at 06:50 AM
ENWEI PHARMACEUTICAL: Vice President completes a reduction of 0.0157%
- Zhitong · Aug 24, 2025 at 08:52 PM
The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHARMACEUTICAL, Zhendong Pharmacy, ZHONGSHENGYAOYE, Hansen Pharmaceutical, and ENWEI PHARMACEUTICAL following suit
- Zhitong · Jul 31, 2025 at 05:39 AM
ENWEI PHARMACEUTICAL: Vice President plans to reduce holdings by 0.0158% of shares
- Zhitong · May 8, 2025 at 07:32 AM
ENWEI PHARMACEUTICAL: Chengdu Jiewei has cumulatively increased its holdings in the company by 199,100 shares
- Zhitong · Apr 20, 2025 at 04:14 AM
ENWEI PHARMACEUTICAL released its 2024 annual performance, with a net profit attributable to the parent company of 37.4975 million yuan, a year-on-year decrease of 56.56%
- Zhitong · Apr 20, 2025 at 04:05 AM
ENWEI PHARMACEUTICAL released its first-quarter performance, with a net profit attributable to the parent company of 16.31 million yuan, a year-on-year increase of 93.56%
